It isn't the Tech that makes ADO Uninvestible, page-104

Good points as for funding last quarter they had around 3 quarters left from memory. If things got very tight they could reduce immediate overheads by offloading a few C-suite execs but unlikely to get to this point in my opinion for the following reasons-
-grants Qld critical mineral grant $1.4M and ARENA $4m are milestone based reimbursement grants we know they are progressing the anode tech at a rapid rate so expect some of these funds to come in this year
-SII- payments for sales of anteobind to Serum Institute India whilst not enough to keep afloat yet will assist with funding life science side and volumes look to be increasing and should continue to go north from here.
-R&D grant loans can be brought forward if really needed as many start ups do around June/July if they can make the 2 quarters funding work in mid year. Would only do this though if something was very close to dropping that would increase market cap and sentiment as the interest is very high.
- A deal with Vidcare, Wyon, Mercedes, Thermo fisher, mobile phone, ear buds or any of the multitude of battery and life science opportunities will bring additional revenue along with a boost to cap and several of these should be close to finalising. We also have a gun sales guy in battery space now and have unleashed Gautam on Indian market so expect this to move rather quickly.
- capital raising ability- you are correct that we will be decimated by dilution at this level for any real meaningful funding but a short term raise for say $2-$4m I think would be easily achievable if it becomes essential. Personally I didn’t contribute to last few raises in any meaningful way as I lost faith in David, the structure of the raises and the ridiculous no news is good news policy and could not see how I would get an immediate return. I would however contribute heavily if I saw a real change in approach to strategy that I felt would get me a return. Suspect I am not the only one, hence buying on market again now as it feels like a change in approach is coming and many of the current relationships that both Manuel and Gautam have fostered should begin to bear fruit. These two chaps along with the teams of scientists behind them will be a big reason we either get rich or die trying. Very happy they are all still with the company and with any luck now empowered more to make it happen.
-equity funding- this will also decimate holders at current market cap but if it was a choice between selling 20% to retail holders or 20% to Mercedes I know which choice I would make. Surprised this didn’t get pushed heavily when cap was higher instead of the crazy discounts and options package raises that were done without any real investor marketing push to show what was happening behind the doors.
-selling IP there is always the opportunity to try to sell one side of the company either batteries or life science, to fund the other. They are structured as seperate entities this would be a last option but still an option.
- If cap got too low might just rope in a few mates and buy the whole damn thing and have a crack at running it! A very very last option but still an option….

I don’t think it’s curtains just yet, where there is life there is hope.

Good luck to all.